Literature DB >> 29722544

Histone acetylation maps in aged mice developmentally exposed to lead: epigenetic drift and Alzheimer-related genes.

Aseel Eid1,2, Syed Waseem Bihaqi2, Christopher Hemme3, John M Gaspar4, Ronald P Hart5, Nasser H Zawia1,3,2.   

Abstract

AIM: Early life exposure to lead (Pb) has been shown to increase late life biomarkers involved in Alzheimer's disease (AD) pathology. Here, we tested the hypothesis that latent over expression of AD-related genes may be regulated through histone activation pathways.
METHODS: Chromatin immunoprecipitation sequencing was used to map the histone activation mark (H3K9Ac) to the mouse genome in developmentally Pb exposed mice on postnatal days 20, 270 and 700.
RESULTS: Exposure to Pb resulted in a global downregulation of H3K9Ac across the lifespan; except in genes associated with the Alzheimer pathway. DISCUSSION: Early life exposure to Pb results in an epigenetic drift in H3K9Ac consistent with latent global gene repression. Alzheimer-related genes do not follow this trend.

Entities:  

Keywords:  Alzheimer's disease; epigenetics; histone acetylation; lead (Pb)

Mesh:

Substances:

Year:  2018        PMID: 29722544      PMCID: PMC5992572          DOI: 10.2217/epi-2017-0143

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  37 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice.

Authors:  Remi Dosunmu; Jinfang Wu; Lina Adwan; Bryan Maloney; Md Riyaz Basha; Christopher A McPherson; G Jean Harry; Deborah C Rice; Nasser H Zawia; Debomoy K Lahiri
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

3.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

4.  Infant exposure to lead (Pb) and epigenetic modifications in the aging primate brain: implications for Alzheimer's disease.

Authors:  Syed Waseem Bihaqi; Hui Huang; Jinfang Wu; Nasser H Zawia
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 5.  Epigenetic studies in Alzheimer's disease: current findings, caveats, and considerations for future studies.

Authors:  Katie Lunnon; Jonathan Mill
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-09-13       Impact factor: 3.568

6.  Genome-wide mapping of in vivo protein-DNA interactions.

Authors:  David S Johnson; Ali Mortazavi; Richard M Myers; Barbara Wold
Journal:  Science       Date:  2007-05-31       Impact factor: 47.728

7.  Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein.

Authors:  J Boyes; A Bird
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

Review 8.  Histone core modifications regulating nucleosome structure and dynamics.

Authors:  Peter Tessarz; Tony Kouzarides
Journal:  Nat Rev Mol Cell Biol       Date:  2014-10-15       Impact factor: 94.444

Review 9.  Role of early life exposure and environment on neurodegeneration: implications on brain disorders.

Authors:  Shweta Modgil; Debomoy K Lahiri; Vijay L Sharma; Akshay Anand
Journal:  Transl Neurodegener       Date:  2014-04-29       Impact factor: 8.014

10.  An integrated encyclopedia of DNA elements in the human genome.

Authors: 
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

View more
  2 in total

Review 1.  The Roles of Histone Modifications in Metal-Induced Neurological Disorders.

Authors:  Yingying Wu; Ruike Wang; Rundong Liu; Yue Ba; Hui Huang
Journal:  Biol Trace Elem Res       Date:  2022-02-07       Impact factor: 3.738

Review 2.  Alzheimer's Disorder: Epigenetic Connection and Associated Risk Factors.

Authors:  Vivek Kumar Sharma; Vineet Mehta; Thakur Gurjeet Singh
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.